{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CAPR/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:52:25.887Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3218,"canonical_name":"CAPRICOR THERAPEUTICS, INC.","cik":"0001133869","uei":null,"lei":null,"duns":null,"ticker":"CAPR"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":44},"count":44,"timeline":[{"ts":"2026-10-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CAPRICOR THERAPEUTICS, INC. — 2026-10-14","url_slug":"/sec/cik-0001133869/schedule-13g-a/0001104659-26-115876","accession_number":"0001104659-26-115876","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — CAPRICOR THERAPEUTICS, INC. — 2026-09-14","url_slug":"/sec/cik-0001133869/schedule-13g/0001104659-26-107591","accession_number":"0001104659-26-107591","importance":55},{"ts":"2026-08-24","kind":"sec.filing","form_type":"8-K","title":"8-K — CAPRICOR THERAPEUTICS, INC. — 2026-08-24","url_slug":"/sec/cik-0001133869/8-k/0001104659-26-100071","accession_number":"0001104659-26-100071","importance":35},{"ts":"2026-08-19","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — CAPRICOR THERAPEUTICS, INC. — 2026-08-19","url_slug":"/sec/cik-0001133869/schedule-13g/0001104659-26-098872","accession_number":"0001104659-26-098872","importance":55},{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CAPRICOR THERAPEUTICS, INC. — 2026-08-14","url_slug":"/sec/cik-0001133869/10-q/0001104659-26-097294","accession_number":"0001104659-26-097294","importance":45},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CAPRICOR THERAPEUTICS, INC. — 2026-08-14","url_slug":"/sec/cik-0001133869/schedule-13g-a/0001214659-26-010417","accession_number":"0001214659-26-010417","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — CAPRICOR THERAPEUTICS, INC. — 2026-08-13","url_slug":"/sec/cik-0001133869/8-k/0001104659-26-095908","accession_number":"0001104659-26-095908","importance":35},{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — CAPRICOR THERAPEUTICS, INC. — 2026-08-07","url_slug":"/sec/cik-0001133869/schedule-13g/0000093751-26-000426","accession_number":"0000093751-26-000426","importance":55},{"ts":"2026-08-03","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — CAPRICOR THERAPEUTICS, INC. — 2026-08-03","url_slug":"/sec/cik-0001133869/schedule-13g/0001346824-26-000208","accession_number":"0001346824-26-000208","importance":55},{"ts":"2026-07-30","kind":"sec.filing","form_type":"8-K","title":"8-K — CAPRICOR THERAPEUTICS, INC. — 2026-07-30","url_slug":"/sec/cik-0001133869/8-k/0001104659-26-088667","accession_number":"0001104659-26-088667","importance":35},{"ts":"2026-07-29","kind":"sec.filing","form_type":"8-K","title":"8-K — CAPRICOR THERAPEUTICS, INC. — 2026-07-29","url_slug":"/sec/cik-0001133869/8-k/0001104659-26-087891","accession_number":"0001104659-26-087891","importance":35},{"ts":"2026-07-14","kind":"sec.filing","form_type":"8-K","title":"8-K — CAPRICOR THERAPEUTICS, INC. — 2026-07-14","url_slug":"/sec/cik-0001133869/8-k/0001104659-26-083559","accession_number":"0001104659-26-083559","importance":35},{"ts":"2026-06-29","kind":"sec.filing","form_type":"4","title":"4 — CAPRICOR THERAPEUTICS, INC. — 2026-06-29","url_slug":"/sec/cik-0001133869/4/0001593086-26-000012","accession_number":"0001593086-26-000012","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"4","title":"4 — CAPRICOR THERAPEUTICS, INC. — 2026-06-29","url_slug":"/sec/cik-0001133869/4/0001593087-26-000013","accession_number":"0001593087-26-000013","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"8-K","title":"8-K — CAPRICOR THERAPEUTICS, INC. — 2026-06-26","url_slug":"/sec/cik-0001133869/8-k/0001104659-26-078327","accession_number":"0001104659-26-078327","importance":35},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Krasney Karen","title":"EVP, GENERAL COUNSEL","shares":24100,"price_per_share":30.38,"usd_value":732158,"security_title":"Common Stock","importance":35.732158},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Bergmann Anthony","title":"CHIEF FINANCIAL OFFICER","shares":24100,"price_per_share":30.38,"usd_value":732158,"security_title":"Common Stock","importance":35.732158},{"ts":"2026-06-25","kind":"sec.insider.24100","reporter":"Krasney Karen","title":"EVP, GENERAL COUNSEL","shares":24100,"price_per_share":30.38,"usd_value":732158,"security_title":"Common Stock","importance":15.732158},{"ts":"2026-06-25","kind":"sec.insider.24100","reporter":"Bergmann Anthony","title":"CHIEF FINANCIAL OFFICER","shares":24100,"price_per_share":30.38,"usd_value":732158,"security_title":"Common Stock","importance":15.732158},{"ts":"2026-06-25","kind":"sec.insider.24100","reporter":"Krasney Karen","title":"EVP, GENERAL COUNSEL","shares":24100,"price_per_share":3.18,"usd_value":76638,"security_title":"Common Stock","importance":15.076638},{"ts":"2026-06-25","kind":"sec.insider.24100","reporter":"Bergmann Anthony","title":"CHIEF FINANCIAL OFFICER","shares":24100,"price_per_share":3.18,"usd_value":76638,"security_title":"Common Stock","importance":15.076638},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Krasney Karen","title":"EVP, GENERAL COUNSEL","shares":24100,"price_per_share":3.18,"usd_value":76638,"security_title":"Common Stock","importance":15.076638},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Bergmann Anthony","title":"CHIEF FINANCIAL OFFICER","shares":24100,"price_per_share":3.18,"usd_value":76638,"security_title":"Common Stock","importance":15.076638},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"Krasney Karen","title":"EVP, GENERAL COUNSEL","shares":400,"price_per_share":30,"usd_value":12000,"security_title":"Common Stock","importance":35.012},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"Bergmann Anthony","title":"CHIEF FINANCIAL OFFICER","shares":400,"price_per_share":30,"usd_value":12000,"security_title":"Common Stock","importance":35.012},{"ts":"2026-06-24","kind":"sec.filing","form_type":"4","title":"4 — CAPRICOR THERAPEUTICS, INC. — 2026-06-24","url_slug":"/sec/cik-0001133869/4/0001593086-26-000010","accession_number":"0001593086-26-000010","importance":30},{"ts":"2026-06-24","kind":"sec.filing","form_type":"4","title":"4 — CAPRICOR THERAPEUTICS, INC. — 2026-06-24","url_slug":"/sec/cik-0001133869/4/0001593087-26-000011","accession_number":"0001593087-26-000011","importance":30},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Krasney Karen","title":"EVP, GENERAL COUNSEL","shares":400,"price_per_share":3.18,"usd_value":1272,"security_title":"Common Stock","importance":15.001272},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Bergmann Anthony","title":"CHIEF FINANCIAL OFFICER","shares":400,"price_per_share":3.18,"usd_value":1272,"security_title":"Common Stock","importance":15.001272},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Krasney Karen","title":"EVP, GENERAL COUNSEL","shares":500,"price_per_share":30,"usd_value":15000,"security_title":"Common Stock","importance":35.015},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Bergmann Anthony","title":"CHIEF FINANCIAL OFFICER","shares":500,"price_per_share":30,"usd_value":15000,"security_title":"Common Stock","importance":35.015},{"ts":"2026-06-22","kind":"sec.insider.m","reporter":"Krasney Karen","title":"EVP, GENERAL COUNSEL","shares":500,"price_per_share":3.18,"usd_value":1590,"security_title":"Common Stock","importance":15.00159},{"ts":"2026-06-22","kind":"sec.insider.m","reporter":"Bergmann Anthony","title":"CHIEF FINANCIAL OFFICER","shares":500,"price_per_share":3.18,"usd_value":1590,"security_title":"Common Stock","importance":15.00159},{"ts":"2026-06-08","kind":"sec.filing","form_type":"8-K","title":"8-K — CAPRICOR THERAPEUTICS, INC. — 2026-06-08","url_slug":"/sec/cik-0001133869/8-k/0001104659-26-071364","accession_number":"0001104659-26-071364","importance":35},{"ts":"2026-05-19","kind":"sec.form144","reporter":"Musket David B","title":"Director","shares":88788,"usd_value":2397256,"security_title":"Common","approx_sale_date":"2026-05-19","accession_number":"0001959173-26-003757","importance":40.4794512},{"ts":"2026-05-19","kind":"sec.form144","reporter":"Musket David B","title":"Director","shares":10000,"usd_value":273200,"security_title":"Common","approx_sale_date":"2026-05-19","accession_number":"0001959173-26-003763","importance":40.05464},{"ts":"2026-05-19","kind":"sec.filing","form_type":"144","title":"144 — CAPRICOR THERAPEUTICS, INC. — 2026-05-19","url_slug":"/sec/cik-0001133869/144/0001959173-26-003757","accession_number":"0001959173-26-003757","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"144/A","title":"144/A — CAPRICOR THERAPEUTICS, INC. — 2026-05-19","url_slug":"/sec/cik-0001133869/144-a/0001959173-26-003763","accession_number":"0001959173-26-003763","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — CAPRICOR THERAPEUTICS, INC. — 2026-05-19","url_slug":"/sec/cik-0001133869/4/0001593087-26-000009","accession_number":"0001593087-26-000009","importance":30},{"ts":"2026-05-18","kind":"sec.insider.m","reporter":"Bergmann Anthony","title":"CHIEF FINANCIAL OFFICER","shares":3000,"price_per_share":1.39,"usd_value":4170,"security_title":"Common Stock","importance":15.00417},{"ts":"2026-05-14","kind":"sec.filing","form_type":"4","title":"4 — CAPRICOR THERAPEUTICS, INC. — 2026-05-14","url_slug":"/sec/cik-0001133869/4/0001310715-26-000004","accession_number":"0001310715-26-000004","importance":30},{"ts":"2026-05-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CAPRICOR THERAPEUTICS, INC. — 2026-05-13","url_slug":"/sec/cik-0001133869/10-q/0001104659-26-060382","accession_number":"0001104659-26-060382","importance":45},{"ts":"2026-05-13","kind":"sec.insider.m","reporter":"Litvack Frank","title":"","shares":3937,"price_per_share":1.39,"usd_value":5472,"security_title":"Common Stock","importance":15.00547243},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — CAPRICOR THERAPEUTICS, INC. — 2026-05-12","url_slug":"/sec/cik-0001133869/8-k/0001104659-26-059380","accession_number":"0001104659-26-059380","importance":35}]}